Annual Working Capital
-$4.46 B
-$13.58 B-148.91%
31 December 2023
Summary:
Pfizer annual working capital is currently -$4.46 billion, with the most recent change of -$13.58 billion (-148.91%) on 31 December 2023. During the last 3 years, it has fallen by -$13.61 billion (-148.77%). PFE annual working capital is now -112.52% below its all-time high of $35.65 billion, reached on 31 December 2012.PFE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$12.00 M
+$6.01 B+100.20%
30 September 2024
Summary:
Pfizer quarterly working capital is currently $12.00 million, with the most recent change of +$6.01 billion (+100.20%) on 30 September 2024. Over the past year, it has dropped by -$42.86 billion (-99.97%). PFE quarterly working capital is now -99.98% below its all-time high of $49.79 billion, reached on 27 September 2009.PFE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -148.9% | -100.0% |
| 3 y3 years | -148.8% | -99.9% |
| 5 y5 years | -124.7% | +100.3% |
PFE Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -126.2% | at low | -100.0% | +100.2% |
| 5 y | 5 years | -124.7% | +0.9% | -100.0% | +100.2% |
| alltime | all time | -112.5% | +0.9% | -100.0% | +100.2% |
Pfizer Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.00 M(-100.2%) |
| June 2024 | - | -$5.99 B(-412.5%) |
| Mar 2024 | - | $1.92 B(-143.0%) |
| Dec 2023 | -$4.46 B(-148.9%) | -$4.46 B(-110.4%) |
| Sept 2023 | - | $42.88 B(+10.8%) |
| June 2023 | - | $38.70 B(+186.3%) |
| Mar 2023 | - | $13.52 B(+48.2%) |
| Dec 2022 | $9.12 B(-46.4%) | $9.12 B(-65.0%) |
| Sept 2022 | - | $26.09 B(+30.1%) |
| June 2022 | - | $20.06 B(+32.4%) |
| Mar 2022 | - | $15.15 B(-11.0%) |
| Dec 2021 | $17.02 B(+86.1%) | $17.02 B(+5.7%) |
| Sept 2021 | - | $16.10 B(+22.4%) |
| June 2021 | - | $13.15 B(+2.1%) |
| Mar 2021 | - | $12.88 B(+40.8%) |
| Dec 2020 | $9.15 B(-303.2%) | $9.15 B(-32.7%) |
| Sept 2020 | - | $13.59 B(-0.8%) |
| June 2020 | - | $13.70 B(+1515.7%) |
| Mar 2020 | - | $848.00 M(-118.8%) |
| Dec 2019 | -$4.50 B(-124.9%) | -$4.50 B(+28.1%) |
| Sept 2019 | - | -$3.52 B(-123.4%) |
| June 2019 | - | $15.04 B(-5.2%) |
| Mar 2019 | - | $15.87 B(-12.2%) |
| Dec 2018 | $18.07 B(+68.6%) | $18.07 B(+43.7%) |
| Sept 2018 | - | $12.57 B(+144.2%) |
| June 2018 | - | $5.15 B(-31.1%) |
| Mar 2018 | - | $7.47 B(-30.3%) |
| Dec 2017 | $10.71 B(+36.8%) | $10.71 B(-11.3%) |
| Sept 2017 | - | $12.07 B(+31.2%) |
| June 2017 | - | $9.20 B(-16.4%) |
| Mar 2017 | - | $11.01 B(+40.6%) |
| Dec 2016 | $7.83 B(-45.6%) | $7.83 B(+109.4%) |
| Sept 2016 | - | $3.74 B(-68.1%) |
| June 2016 | - | $11.75 B(-6.5%) |
| Mar 2016 | - | $12.56 B(-12.8%) |
| Dec 2015 | $14.40 B(-57.6%) | $14.40 B(-16.0%) |
| Sept 2015 | - | $17.16 B(-37.8%) |
| June 2015 | - | $27.57 B(-5.6%) |
| Mar 2015 | - | $29.22 B(-14.1%) |
| Dec 2014 | $34.01 B(+3.4%) | $34.01 B(-8.3%) |
| Sept 2014 | - | $37.07 B(+2.0%) |
| June 2014 | - | $36.35 B(+10.1%) |
| Mar 2014 | - | $33.00 B(+0.4%) |
| Dec 2013 | $32.88 B(-7.8%) | $32.88 B(-16.0%) |
| Sept 2013 | - | $39.13 B(+3.0%) |
| June 2013 | - | $37.98 B(+2.1%) |
| Mar 2013 | - | $37.22 B(+4.4%) |
| Dec 2012 | $35.65 B(+11.7%) | $35.65 B(+27.3%) |
| Sept 2012 | - | $28.00 B(+0.1%) |
| June 2012 | - | $27.97 B(+0.7%) |
| Mar 2012 | - | $27.77 B(-13.0%) |
| Dec 2011 | $31.91 B(+0.2%) | $31.91 B(-8.5%) |
| Sept 2011 | - | $34.88 B(+16.2%) |
| June 2011 | - | $30.01 B(+3.2%) |
| Mar 2011 | - | $29.07 B(-8.7%) |
| Dec 2010 | $31.86 B(+30.3%) | $31.86 B(+6.5%) |
| Sept 2010 | - | $29.92 B(+13.2%) |
| June 2010 | - | $26.42 B(+10.1%) |
| Mar 2010 | - | $23.99 B(-1.9%) |
| Dec 2009 | $24.45 B(+52.1%) | $24.45 B(-50.9%) |
| Sept 2009 | - | $49.79 B(+9.6%) |
| June 2009 | - | $45.44 B(+47.0%) |
| Mar 2009 | - | $30.91 B(+92.4%) |
| Dec 2008 | $16.07 B(-35.8%) | $16.07 B(-39.9%) |
| Sept 2008 | - | $26.72 B(+5.0%) |
| June 2008 | - | $25.46 B(-13.2%) |
| Mar 2008 | - | $29.33 B(+17.3%) |
| Dec 2007 | $25.01 B(-2.1%) | $25.01 B(-9.1%) |
| Sept 2007 | - | $27.51 B(+3.9%) |
| June 2007 | - | $26.49 B(-8.8%) |
| Mar 2007 | - | $29.04 B(+13.6%) |
| Dec 2006 | $25.56 B | $25.56 B(+21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $21.03 B(+0.4%) |
| June 2006 | - | $20.94 B(+18.0%) |
| Mar 2006 | - | $17.74 B(-3.7%) |
| Dec 2005 | $18.42 B(+45.9%) | $18.42 B(+48.9%) |
| Sept 2005 | - | $12.37 B(+12.4%) |
| June 2005 | - | $11.01 B(-17.9%) |
| Mar 2005 | - | $13.40 B(+6.1%) |
| Dec 2004 | $12.63 B(+86.6%) | $12.63 B(-8.6%) |
| Sept 2004 | - | $13.82 B(+19.9%) |
| June 2004 | - | $11.53 B(+7.2%) |
| Mar 2004 | - | $10.75 B(+58.9%) |
| Dec 2003 | $6.77 B(+8.7%) | $6.77 B(-40.7%) |
| Sept 2003 | - | $11.41 B(-9.4%) |
| June 2003 | - | $12.59 B(+1.9%) |
| Mar 2003 | - | $12.35 B(+98.3%) |
| Dec 2002 | $6.23 B(+13.6%) | $6.23 B(+18.2%) |
| Sept 2002 | - | $5.27 B(-13.2%) |
| June 2002 | - | $6.07 B(-2.8%) |
| Mar 2002 | - | $6.24 B(+13.8%) |
| Dec 2001 | $5.48 B(+5.3%) | $5.48 B(-21.2%) |
| Sept 2001 | - | $6.96 B(-8.6%) |
| June 2001 | - | $7.61 B(-2.7%) |
| Mar 2001 | - | $7.82 B(+50.3%) |
| Dec 2000 | $5.21 B(+17.9%) | $5.21 B(+7.9%) |
| Sept 2000 | - | $4.82 B(+34.1%) |
| June 2000 | - | $3.60 B(+21.8%) |
| Mar 2000 | - | $2.96 B(-33.1%) |
| Dec 1999 | $4.42 B(+61.2%) | $4.42 B(+84.6%) |
| Sept 1999 | - | $2.39 B(+2.2%) |
| June 1999 | - | $2.34 B(-21.9%) |
| Mar 1999 | - | $3.00 B(+9.4%) |
| Dec 1998 | $2.74 B(+11.9%) | $2.74 B(+4.7%) |
| Sept 1998 | - | $2.62 B(+23.3%) |
| June 1998 | - | $2.12 B(+22.8%) |
| Mar 1998 | - | $1.73 B(-29.5%) |
| Dec 1997 | $2.45 B(+195.7%) | $2.45 B(+67.8%) |
| Sept 1997 | - | $1.46 B(+58.4%) |
| June 1997 | - | $921.00 M(-19.6%) |
| Mar 1997 | - | $1.15 B(+38.4%) |
| Dec 1996 | $828.00 M(-14.2%) | $828.00 M(+36.4%) |
| Sept 1996 | - | $607.00 M(-5.6%) |
| June 1996 | - | $643.00 M(-30.4%) |
| Mar 1996 | - | $924.00 M(-4.3%) |
| Dec 1995 | $965.20 M(+0.3%) | $965.20 M(+185.9%) |
| Sept 1995 | - | $337.60 M(-380.4%) |
| June 1995 | - | -$120.40 M(-354.0%) |
| Mar 1995 | - | $47.40 M(-95.1%) |
| Dec 1994 | $962.50 M(-25.4%) | $962.50 M(-25.2%) |
| Sept 1994 | - | $1.29 B(+45.3%) |
| June 1994 | - | $885.50 M(-25.8%) |
| Mar 1994 | - | $1.19 B(-7.5%) |
| Dec 1993 | $1.29 B(-40.5%) | $1.29 B(-16.8%) |
| Sept 1993 | - | $1.55 B(-6.1%) |
| June 1993 | - | $1.65 B(-9.3%) |
| Mar 1993 | - | $1.82 B(-16.1%) |
| Dec 1992 | $2.17 B(+56.2%) | $2.17 B(-10.3%) |
| Sept 1992 | - | $2.42 B(+30.9%) |
| June 1992 | - | $1.85 B(+11.1%) |
| Mar 1992 | - | $1.66 B(+19.7%) |
| Dec 1991 | $1.39 B(+5.2%) | $1.39 B(+22.2%) |
| Sept 1991 | - | $1.14 B(+3.2%) |
| June 1991 | - | $1.10 B(-23.1%) |
| Mar 1991 | - | $1.43 B(+8.4%) |
| Dec 1990 | $1.32 B(-17.2%) | $1.32 B(+9.1%) |
| Sept 1990 | - | $1.21 B(-12.7%) |
| June 1990 | - | $1.38 B(-18.3%) |
| Mar 1990 | - | $1.69 B(+6.3%) |
| Dec 1989 | $1.59 B(-9.0%) | $1.59 B(-9.0%) |
| Dec 1988 | $1.75 B(-18.4%) | $1.75 B(-18.4%) |
| Dec 1987 | $2.14 B(+83.4%) | $2.14 B(+83.4%) |
| Dec 1986 | $1.17 B(-2.4%) | $1.17 B(-2.4%) |
| Dec 1985 | $1.20 B(-11.6%) | $1.20 B(-11.6%) |
| Dec 1984 | $1.35 B | $1.35 B |
FAQ
- What is Pfizer annual working capital?
- What is the all time high annual working capital for Pfizer?
- What is Pfizer annual working capital year-on-year change?
- What is Pfizer quarterly working capital?
- What is the all time high quarterly working capital for Pfizer?
- What is Pfizer quarterly working capital year-on-year change?
What is Pfizer annual working capital?
The current annual working capital of PFE is -$4.46 B
What is the all time high annual working capital for Pfizer?
Pfizer all-time high annual working capital is $35.65 B
What is Pfizer annual working capital year-on-year change?
Over the past year, PFE annual working capital has changed by -$13.58 B (-148.91%)
What is Pfizer quarterly working capital?
The current quarterly working capital of PFE is $12.00 M
What is the all time high quarterly working capital for Pfizer?
Pfizer all-time high quarterly working capital is $49.79 B
What is Pfizer quarterly working capital year-on-year change?
Over the past year, PFE quarterly working capital has changed by -$42.86 B (-99.97%)